GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helix BioPharma Corp (TSX:HBP) » Definitions » General and Admin. Expense

Helix BioPharma (TSX:HBP) General and Admin. Expense : C$2.39 Mil (TTM As of Jan. 2025)


View and export this data going back to 1996. Start your Free Trial

What is Helix BioPharma General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Helix BioPharma's General and Admin. Expense for the three months ended in Jan. 2025 was C$0.02 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Jan. 2025 was C$2.39 Mil.

Helix BioPharma General and Admin. Expense Historical Data

The historical data trend for Helix BioPharma's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helix BioPharma General and Admin. Expense Chart

Helix BioPharma Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.72 1.69 0.60 0.30 2.58

Helix BioPharma Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.07 2.27 0.03 0.02

Helix BioPharma General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$2.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Helix BioPharma General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Helix BioPharma's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Helix BioPharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helix BioPharma Corp (TSX:HBP) » Definitions » General and Admin. Expense
Comparable Companies
XCNQ:DTC TSX:MBX TSXV:SHRX TSXV:NRX TSXV:TTI NEOE:BMND TSX:BCT TSXV:GSD XCNQ:DOSE TSX:SVA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
HBP0:Germany
Address
40 Temperance Street, Suite 2700, Bay Adelaide Centre - North Tower, Toronto, ON, CAN, M5H0B4
Website
https://www.helixbiopharma.com
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidate is L-DOS47 for Tumor Defence Breaker is in clinical trials for pancreatic cancer.